Food and Drug Administration: FDA Approves New Medication for Chronic Weight Management American Diabetes Association: Tirzepatide Returns to the Spotlight on the Final Day of the Scientific Sessions Tirzepatide Once Weekly for the Treatment of Obesity The New England Journal of Medicine : Sheryl Huggins Salomon Author Sheryl Huggins Salomon has spent her career equipping people with information to help improve their well-being and prospects in life
Faster absorption means more semaglutide reaching GLP-1 receptors in a shorter time window, and those receptors in the brain and gut respond accordingly
Right now, an incredible 74% of adults in the United states are overweight, including 43% who tip the scales into obesity
bound to haptocorrin and transcobalamin, can be tested in serum
Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimers A peptide
In the head-to-head SURMOUNT-5 trial (NEJM, 2025), Mounjaro produced 20.2% average weight loss vs 13.7% for Wegovy over 72 weeks